Neumora Therapeutics, Inc. (NMRA) Gets a Hold from Stifel Nicolaus

Tip Ranks
2025.11.17 12:18
portai
I'm PortAI, I can summarize articles.

Stifel Nicolaus maintained a Hold rating on Neumora Therapeutics, Inc. with a $3.00 price target. William Blair's Myles Minter also issued a Hold rating, while Mizuho Securities reiterated a Buy rating on November 12.

Stifel Nicolaus analyst maintained a Hold rating on Neumora Therapeutics, Inc. today and set a price target of $3.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

In addition to Stifel Nicolaus, Neumora Therapeutics, Inc. also received a Hold from William Blair’s Myles Minter in a report issued on November 7. However, on November 12, Mizuho Securities reiterated a Buy rating on Neumora Therapeutics, Inc. (NASDAQ: NMRA).

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer